Compare price, profitability, solvency, and SEC-reported financials side by side—before deciding which assumptions deserve a closer look.
FY 2026 · View financials
Decision snapshot: NVAX stock price vs ETD: inconclusive Relative valuation is incomplete for this pair. Review the available filing metrics before drawing a conclusion.
Quick read
Each company valued on the other's multiple, then compared with the market price.
Implied fair value · at ETD's multiple
Needs ETD P/E.
Implied fair value · at NVAX's multiple
Needs NVAX P/E.
Price unavailable
Metric by metric
Where each company leads, and how wide the gap is.
Growth edge
Pricing power
Operating leverage
Lower is better
Not comparable
Lower leverage
Statements
Core statements aligned to each company's latest fiscal year.
SEC periods: NVAX FY 2025 (ended Dec 31, 2025) · ETD FY 2026 (ended Jun 30, 2026). Fiscal years are not aligned.
Trendline
Seven fiscal years of revenue, earnings, and margins before underwriting a re-rating.
Price framework
Market cap plus debt, less cash.
Price framework
Discounted free cash flow, then bridged to a per-share price. Same assumptions applied to both companies.
NOVAVAX INC · implied price per share
Bear
$24.71
Base
$29.07
Bull
$33.44
Ethan Allen Interiors Inc. · implied price per share
Bear
$28.99
Base
$34.11
Bull
$39.22
Balance sheet health
Financial health checks to separate durable balance sheets from potential value traps.
Financial strength on a 0–9 scale.
Bankruptcy-risk signal from balance sheet and earnings power.
Not enough data to score either balance sheet.
Debt / equity
Total debt against shareholders' equity
-0.00x
0.11x
Net debt / EBITDA
Leverage against operating earnings
-1.55x
-0.76x
Cash and equivalents
Liquid reserves on the balance sheet
$735.08M
$133.25M
Total debt
Interest-bearing obligations outstanding
Comparable set
Where the pair sits against the wider comparable set.
Keep comparing
Open adjacent comparisons from the same industry to pressure-test the read across multiple pairs.
Moderna, Inc.
NVAX vs MRNA
BioNTech SE
NVAX vs BNTX
Emergent BioSolutions Inc.
NVAX vs EBS
ASTRAZENECA PLC
NVAX vs AZN
GSK plc
NVAX vs GSK
RH
NVAX vs RH
LA-Z-BOY INC
NVAX vs LZB
LEGGETT & PLATT INC
NVAX vs LEG
ADVANCE AUTO PARTS INC
NVAX vs AAP
NORDSTROM INC
NVAX vs JWN
ROSS STORES, INC.
NVAX vs ROST
$395.00K
$50.55M
Live quote
LLM-powered synthesis
An on-demand narrative read of the same deterministic data.
The deterministic comparison remains available. Sign in when you want an on-demand narrative synthesis of the same data.
Price unavailable
